Peptides That Bind Specifically to an Antibody from a Chronic Lymphocytic Leukemia Clone Expressing Unmutated Immunoglobulin Variable Region Genes
Abstract Chronic lymphocytic leukemia (CLL) is a clonal disease of a subset of human B lymphocytes. Although the cause of the disease is unknown, its development and evolution appear to be promoted by signals delivered when B-cell receptors (BCRs) engage (auto)antigens. Here, using a peptide phage d...
Saved in:
Main Authors: | Yun Liu (Author), Chelsea D Higgins (Author), Cathie M Overstreet (Author), Kanti R Rai (Author), Nicholas Chiorazzi (Author), Jonathan R Lai (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2013-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation
by: Rosa Catera, et al.
Published: (2017) -
Unmuting Medical Students' Education: Utilizing Telemedicine During the COVID-19 Pandemic and Beyond
by: Iancu, Ariella Magen, et al.
Published: (2020) -
Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia
by: Angelina Konovalova, et al.
Published: (2023) -
Correction to: Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells
by: Carlo Calissano, et al.
Published: (2022) -
Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders
by: R Poongodi, et al.
Published: (2018)